History

A list of downloadable documents created during development.

Background information

Gastrointestinal stromal tumours (unresectable/metastatic) - imatinib (review): Equality impact assessment

Gastrointestinal stromal tumours (unresectable/metastatic) - imatinib (review): rejected appeal

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): final appraisal determination

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): appraisal consultation

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): assessment report

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): final protocol

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): final scope

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): final matrix of consultee and commentators

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): Institute's response to consultee and commentator comments on the draft scope

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): draft scope

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): provisional matrix of consultee and commentators